Revel Health review

What it is

Revel Health is a telehealth storefront that pairs GLP-1 weight care with a longevity line, organised into Longevity, Weight Loss, Energy & Vitality and Recovery & Performance. Its products are sermorelin injections and a sermorelin oral dissolving tablet, NAD⁺ injections, NAD⁺ nasal spray and an NAD⁺ face cream, glutathione injection, B12 and B12/MIC injections, and semaglutide and tirzepatide oral dissolving tablets. It states clearly on every product page that it is not a pharmacy and that it connects patients with licensed healthcare professionals who determine eligibility, with compounding described as taking place in USP 795/800-compliant facilities.

How it works

Buy-then-be-assessed, but with the money-back valve most competitors omit. You select a care program, complete a medical questionnaire, a board-certified provider reviews it — the site claims review inside the hour — and if a prescription is issued, medication ships discreetly in three to five days. If you are not approved, Revel states a 100% refund. That single line resolves the biggest objection to a storefront model where you pay before anyone has looked at your history, and it is worth more than most of the trust badges on this board. What comes with the price is spelled out on each card: board-certified provider review, medication and dispensing supplies, discreet delivery, unlimited provider communication, and the refund guarantee. The gaps are geography and sourcing. Coverage is 45 states, with Alaska, Arkansas, North Carolina, New Jersey and Mississippi excluded — a clear list, which is more than most publish, but a shorter one than the 50-state claims elsewhere in this batch. The compounding standard is stated as USP 795/800 without any pharmacy being named, no medical director is identified, and the product pages carry member testimonials whose star displays we give no weight to. A $50 first-order discount applies automatically at checkout, so budget against the standing rate rather than the first charge.

Pricing transparency

Published on every product page, which is the change worth recording. The Sermorelin Injection Care Program is $149, the NAD⁺ Injection Care Program $169 and the NAD⁺ Nasal Spray Care Program $125, with a sermorelin oral dissolving tablet, glutathione injection, NAD⁺ face cream and B12 options alongside. Each is a care program rather than a bare vial: board-certified provider review, the medication, dispensing supplies, three-to-five-day discreet delivery, unlimited provider communication and the full refund if you are not approved are all inside the figure. Two caveats. The $50-off-first-order promotion applies automatically at checkout, so your first charge is not your ongoing charge — budget against the list price. And no dose, concentration or vial size is stated beside any of these numbers, so what a program actually contains is undefined; ask before you subscribe, because that is the variable that separates two apparently identical $149 sermorelin plans. Its GLP-1 pricing is separate and, unlike the longevity line, still not shown upfront — that side of the business is the part its record was describing.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Revel states on each product page that it is not a pharmacy, that a licensed provider reviews your questionnaire and prescribes only if medically appropriate, and that its compounding facilities are USP 795/800-compliant — a real standard covering non-sterile and sterile compounding practice, though it is a facility standard rather than FDA approval of the product, and no pharmacy is named. On the evidence, the longevity line splits three ways. Sermorelin is a GHRH analogue that signals your pituitary to release your own growth hormone, which the product page describes accurately; the mechanism is well characterised and the long-term human outcome data behind the recovery, sleep and energy claims remains thin. Injected and intranasal NAD⁺ have no controlled human outcome trials at all — the single human intravenous study was a pharmacokinetic pilot finding infused NAD⁺ clears from plasma quickly — and the NAD⁺ forms with human trial data are the oral precursors NR and NMN, which reliably raise blood NAD⁺: a raised biomarker, not a demonstrated clinical benefit. Injectable glutathione has essentially no controlled human outcome data behind the skin-brightness and detoxification claims. An NAD⁺ face cream is further still from anything the evidence supports. Individual results vary.

Pros and watch-outs

The evidence behind what Revel Health prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• Glutathione: the master antioxidant, and where the evidence actually is

  Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.

How Revel Health compares

A few alternatives worth a look, depending on what you’re optimizing for.

• RRRewinding RX

  NAD⁺ buyers who want concentration, vial size and a dosing ladder published with the price

  See Rewinding RX →
• RHRxION Health

  A flat NAD⁺ price from a platform that says on the page what the evidence does not support

  See RxION Health →
• REREMEVi

  Choosing between injected, nasal and oral NAD⁺ without the price changing

  See REMEVi →